Many anti-diabetic drugs are now available to treat type 2 diabetes mellitus, including sulfonylureas, glinides, α-glucosidase inhibitors, thiazolidinediones, incretin-related drugs, glucagon-like peptide-1 (GLP-1) analogues, sodium-glucose co-transporter 2 (SGLT2) inhibitors and, certainly, metformin. It holds a central position, given its role in reducing hyperglycemia and the risk of life-threatening complications. The International Diabetes Federation annually confirms the appropriateness of the appointment of metformin as a first step in the treatment of type 2 diabetes mellitus along with lifestyle modification [1]
Type 2 diabetes is a common disease in the United States that can result in life-threatening cardiac...
Metformin, a biguanide derivative, has been used in the treatment of type 2 diabetes for nearly 50 y...
Current guidelines and clinical studies for the treatment of Type 2 Diabetes Mellitus (T2DM) all sup...
Metformin has been used successfully since the 1950s as first line pharmacotherapy to treat people w...
Metformin is the most commonly used glucose-lowering therapy (GLT) worldwide and remains the first-l...
Metformin is one of the oldest oral treatments to reduce hyperglycaemia in people with diabetes. Gas...
Metformin — first-line drug for the treatment of diabetes mellitus (DM) type 2, the use of which red...
With the sulphonylurea gliclazide and insulin, metformin is part of the triad of antihyperglycaemic ...
This review considers the therapeutic choices currently faced by people with type 2 diabetes and tho...
Till the turn of the century, treatment of hyperglycemia in Type 2 diabetes was limited to two main ...
Type 2 diabetes is a disease plaguing the American population, bringing along with it a number of co...
Against hyperglycemic specialists, the biguanide metformin is the most known and effective, highligh...
Abstract During the last decade we experienced a surge in the number of glucose loweri...
Optimal control of hyperglycemia and associated risk factors reduces the risk of diabetes-related co...
Background: There are multiple glucose-lowering drugs available as alternative initial monotherapy f...
Type 2 diabetes is a common disease in the United States that can result in life-threatening cardiac...
Metformin, a biguanide derivative, has been used in the treatment of type 2 diabetes for nearly 50 y...
Current guidelines and clinical studies for the treatment of Type 2 Diabetes Mellitus (T2DM) all sup...
Metformin has been used successfully since the 1950s as first line pharmacotherapy to treat people w...
Metformin is the most commonly used glucose-lowering therapy (GLT) worldwide and remains the first-l...
Metformin is one of the oldest oral treatments to reduce hyperglycaemia in people with diabetes. Gas...
Metformin — first-line drug for the treatment of diabetes mellitus (DM) type 2, the use of which red...
With the sulphonylurea gliclazide and insulin, metformin is part of the triad of antihyperglycaemic ...
This review considers the therapeutic choices currently faced by people with type 2 diabetes and tho...
Till the turn of the century, treatment of hyperglycemia in Type 2 diabetes was limited to two main ...
Type 2 diabetes is a disease plaguing the American population, bringing along with it a number of co...
Against hyperglycemic specialists, the biguanide metformin is the most known and effective, highligh...
Abstract During the last decade we experienced a surge in the number of glucose loweri...
Optimal control of hyperglycemia and associated risk factors reduces the risk of diabetes-related co...
Background: There are multiple glucose-lowering drugs available as alternative initial monotherapy f...
Type 2 diabetes is a common disease in the United States that can result in life-threatening cardiac...
Metformin, a biguanide derivative, has been used in the treatment of type 2 diabetes for nearly 50 y...
Current guidelines and clinical studies for the treatment of Type 2 Diabetes Mellitus (T2DM) all sup...